The Journal of the Korean dental association (대한치과의사협회지)

The Korean Dental Association (대한치과의사협회)
권호 표지

The General Management and Treatment of Neuropathic Pain

전반적인 신경병성 통증의 조절 및 치료

  • Chun, Yang-Hyun (Department of Oral Medicine, School of Dentistry, Kyung Hee University, Chronic Orofacial Pain Clinic, Kyung Hee Medical Center)
  • 전양현 (경희대학교 치의학전문대학원 구강내과학교실, 경희의료원 만성구강안면통증센터)
  • Published : 2011.06.01
Download PDF
⟨ Previous Next ⟩

Abstract

Clinically, treatment goal of neuropathic pain focused on not elimination of etiology but management and control of symptoms because we don't know certain about clear etiology of neuropathic pain yet. The drugs used for the management of neuropathic pain were classified as drugs with strong evidence for benefit(antidepressants, anticonvulsants, opioid analgesics etc.), modest evidence for benefit(mexiletine, carbamazepine, clonidine etc.), preliminary evidence for benefit(NSAIDs, dextromethorphan, topiramate etc.). Finally, the treatment for trigeminal neuralgia was outlined separately since this disorder responds to a different group of drugs than other neuropathic pain conditions.

Keywords

References

  1. 전양현, 강수경, 정성희, 어규식, 흥정표 : 구강안면 통증의 이해, 2판, 지성출판사, 서울, 2010년, 195-202.
  2. 전양현, 강수경, 정성희, 어규식, 홍정표 : 구강안면 통증, 분류, 평가 및 치료를 위한 지침, 4판, 지성출판사 서울, 2010년, 83-100.
  3. 정성창, 김영구 등 : 구강안면동통과 측두하악장애, 2판. 신흥인터내셔날, 서울, 2006년, 212-242.
  4. Attal N, Cruccu G, Haanpaa M, et al. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol 2006; 13: 1153-1169. https://doi.org/10.1111/j.1468-1331.2006.01511.x
  5. Flnnerup NB, Otto M, McQuay HJ, et al. Algorithm for neuropathic pain treatment: An evidence based proposal. Pain 2005; 118: 289-305. https://doi.org/10.1016/j.pain.2005.08.013
  6. Gilron I, Max MB. Combination pharmacotherapy for neuropathic pain: Current evidence and future directions. Expert Rev Neurother 2005;5:823-830. https://doi.org/10.1586/14737175.5.6.823
  7. Raja SN, Haythornthwaite JA, Pappagallo M, et al. Opioids versus antidepressants in postherpetic neuralgia: A randomized, placebo-controlled trial. Neurology 2002; 59:1015-1021. https://doi.org/10.1212/WNL.59.7.1015
  8. Watson CP, Babul N. Efficacy of oxycodone in neuropathic pain: A randomized trial in postherpetic neuralgia. Neurology 1998;50: 1837-1841. https://doi.org/10.1212/WNL.50.6.1837
  9. Portenoy RK. Opioid therapy for chronic nonmalignant pain: A review of the critical issues. J Pain Symptom Manage 1996;11 :203-217.
  10. Cohen SP, Abdi S. New developments in the use of tricyclic antidepressants for the management of pain. Curr Opin Anaesthesiol 2001; 14:505-511. https://doi.org/10.1097/00001503-200110000-00008
  11. McQuay HJ, Tramer M, Nye SA, Carroll D, Wiffen PJ, Moore RA. A systematic review of antidepressants in neuropathic pain. Pain 1996;68:217-227. https://doi.org/10.1016/S0304-3959(96)03140-5
  12. Wernicke JF, Pritchett YL, D' 'Souza DN, et al. A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain. Neurology 2006; 67: 1411-1420. https://doi.org/10.1212/01.wnl.0000240225.04000.1a
  13. Sindrup SH, Bjerre U, Dejgaard A, Srosen K, Aaes-Jorgensen T, Gram LF. The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy. Clin Pharmacol Ther 1992;52:547-552. https://doi.org/10.1038/clpt.1992.183
  14. Grabow TS, Dougherty PM. Gabapentin produces dosedependent antinociception in the orofacial formalin test in the rat. Reg Anesth Pain Med 2002; 27: 277-283.
  15. Rowbotham M, Harden N, Stacey B, Bernstein P, Magnus-Miller L. Gabapentin for the treatment of postherpetic neuralgia: A randomized controlled trial. JAMA 1998;280:1837-1842. https://doi.org/10.1001/jama.280.21.1837
  16. Richter RW, Portenoy R, Sharma U, Lamoreaux L. Bockbrader H, Knapp LE. Relief of painful diabetic peripheral neuropathy with pregabalin: A randomized, placebo-controlled trial. J Pain 2005;6:253-260. https://doi.org/10.1016/j.jpain.2004.12.007
  17. Lynch ME, Clark AJ, Sawynok J, Sullivan MJ. Topical 2% amitriptyline and 1 % ketamine in neuropathic pain syndromes: A randomized, double-blind, placebo-controlled trial. Anesthesiology 2005; 103: 140-146. https://doi.org/10.1097/00000542-200507000-00021
  18. yas-Smith MO, Max MB, Muir J, Kingman A. Transdermal clonidine compared to placebo in painful diabetic neuropathy using a two-stage 'enriched enrollment' design. Pain 1995;60:267-274. https://doi.org/10.1016/0304-3959(94)00121-T
  19. Sang CN, Booher S, Gilron I, Parada S, Max MB. Dextromethorphan and memantine in painful diabetic neuropathy and postherpetic neuralgia: Efficacy and doseresponse trials. Anesthesiology 2002; 96: 1053-1061. https://doi.org/10.1097/00000542-200205000-00005
  20. Gilron I, Booher SL. Rowan MS, Smoller MS, Max MB. A randomized, controlled trial of high-dose dextromethorphan in facial neuralgias. Neurology 2000 ;55:964-971. https://doi.org/10.1212/WNL.55.7.964
  21. Raskin p, Donofrio PD, Rosenthal NR, et al. Topiramate vs placebo in painful diabetic neuropathy: Analgesic and metabolic effects. Neurology 2004;63:865-873. https://doi.org/10.1212/01.WNL.0000137341.89781.14
  22. Zakrzewska JM, Lopez BC. Trigeminal neuralgia. Clin Evid 2006;(15): 1827-1835.
  23. Fromm GH, Terrence CF. Comparison of L-baclofen and racemic baclofen in trigeminal neuralgia. Neurology 1987; 37: 1725-1728.202. https://doi.org/10.1212/WNL.37.11.1725